Use of respiratory medication in five Latin American cities: The PLATINO study.

[1]  A. Menezes,et al.  Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study. , 2008, Respiratory medicine.

[2]  C. P. Schayck,et al.  Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. , 2008, Family practice.

[3]  J. Jardim,et al.  Tratamiento de la EPOC en 5 ciudades de América Latina: estudio PLATINO , 2008 .

[4]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[5]  G. Viegi,et al.  Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples. , 2008, Respiratory medicine.

[6]  L. Akinbami,et al.  National surveillance for asthma--United States, 1980-2004. , 2007, Morbidity and mortality weekly report. Surveillance summaries.

[7]  D. Mannino,et al.  The epidemiology and economics of chronic obstructive pulmonary disease. , 2007, Proceedings of the American Thoracic Society.

[8]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[9]  S. Thirstrup,et al.  Prevalence of inappropriate prescribing in primary care , 2007, Pharmacy World & Science.

[10]  G. Valdivia,et al.  Diagnostic labeling of COPD in five Latin American cities. , 2007, Chest.

[11]  Saunak Sen,et al.  Polypharmacy and Prescribing Quality in Older People , 2006, Journal of the American Geriatrics Society.

[12]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[13]  J. Jardim,et al.  Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad , 2006 .

[14]  S. Braman.  The global burden of asthma. , 2006, Chest.

[15]  G. Valdivia,et al.  [Spirometric reference values in 5 large Latin American cities for subjects aged 40 years or over]. , 2006, Archivos de bronconeumologia.

[16]  R. Sequeira,et al.  Health care providers' perceptions of the problems and causes of irrational use of drugs in two Middle East countries , 2006, International journal of clinical practice.

[17]  Cesar G Victora,et al.  Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.

[18]  J. L. Izquierdo Alonso,et al.  [Factors affecting drug prescription in patients with stable COPD: results from a multicenter Spanish study (IDENTEPOC)]. , 2005, Archivos de bronconeumologia.

[19]  Lesley H Curtis,et al.  Inappropriate prescribing for elderly Americans in a large outpatient population. , 2004, Archives of internal medicine.

[20]  C. Victora,et al.  The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities , 2004, BMC medical research methodology.

[21]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[22]  P. Hernandez,et al.  Overdiagnosis of asthma in the community. , 2004, Canadian respiratory journal.

[23]  N. Magrini,et al.  Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989 , 1992, European Journal of Clinical Pharmacology.

[24]  J. Díez,et al.  Tratamiento farmacológico de la EPOC en dos niveles asistenciales. Grado de adecuación a las normativas recomendadas , 2003 .

[25]  N. Roche,et al.  Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[26]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[27]  Christine Jenkins,et al.  GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY , 2001 .

[28]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[29]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[30]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[31]  D. Joyce,et al.  Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. , 1996, Chest.

[32]  M. Connolly,et al.  Prevalence and treatment of chronic airways obstruction in adults over the age of 45. , 1996, Thorax.